HIM
APYX icon

Hillsdale Investment Management’s Apyx Medical APYX Stock Holding History

Hillsdale Investment Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$643K Buy
174,300
+79,800
+84% +$298K 0.02% 414
2025
Q4 		$331K Buy
+94,500
New +$330K 0.01% 464

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Hillsdale Investment Management's APYX Position: Q1 2026 in Review

Hillsdale Investment Management increased its Apyx Medical (APYX) stake by 84% in Q1 2026, buying an estimated $298K and bringing the position to 174,300 shares worth $643K. The position accounts for 0.02% of the portfolio, ranked #414.

Hillsdale Investment Management first reported a position in APYX in Q4 2025 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Hillsdale Investment Management held 174,300 shares of Apyx Medical worth $643K as of Q1 2026.
  • Hillsdale Investment Management bought 79,800 Apyx Medical shares in Q1 2026, an estimated $298K.
  • Apyx Medical made up 0.02% of Hillsdale Investment Management's portfolio in Q1 2026, its #414 holding.
  • Hillsdale Investment Management first reported a position in Apyx Medical in Q4 2025 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.